Online Database of Chemicals from Around the World

Etomidate
[CAS# 33125-97-2]

List of Suppliers
CAS: 33125-97-2
Product: Etomidate
No suppilers available.
Identification
Classification API >> Anesthetic agents >> General anesthetics
Name Etomidate
Synonyms 1-(1-Phenylethyl)imidazole-5-carboxylic acid ethyl ester; Amidate
Molecular Structure CAS # 33125-97-2, Etomidate, 1-(1-Phenylethyl)imidazole-5-carboxylic acid ethyl ester, Amidate
Molecular Formula C14H16N2O2
Molecular Weight 244.29
CAS Registry Number 33125-97-2
EC Number 251-385-9
SMILES CCOC(=O)C1=CN=CN1[C@H](C)C2=CC=CC=C2
Properties
Solubility 63.2 mg/L (25 ºC water)
Density 1.1±0.1 g/cm3, Calc.*
Index of Refraction 1.562, Calc.*
Melting point 135.44 ºC
Boiling Point 391.5±17.0 ºC (760 mmHg), Calc.*, 384.70 ºC
Flash Point 190.6±20.9 ºC, Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software.
Safety Data
Hazard Symbols symbol symbol   GHS07;GHS09 Warning    Details
Hazard Statements H302-H332-H400    Details
Precautionary Statements P261-P264-P270-P271-P273-P301+P317-P304+P340-P317-P330-P391-P501    Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Acute toxicityAcute Tox.4H302
Acute hazardous to the aquatic environmentAquatic Acute1H400
Acute toxicityAcute Tox.4H332
Chronic hazardous to the aquatic environmentAquatic Chronic1H410
Chronic hazardous to the aquatic environmentAquatic Chronic2H411
SDS Available
up Discovory and Applicatios
Etomidate, a short-acting intravenous anesthetic agent, was discovered in the 1960s by Janssen Pharmaceutica. Initially developed as a potential anticonvulsant, its remarkable anesthetic properties were soon recognized. The compound's ability to induce rapid anesthesia with minimal cardiovascular and respiratory depression made it an attractive option for use in medical procedures where rapid onset and offset of anesthesia are desired.

Etomidate is primarily used for the induction of general anesthesia. Its rapid onset of action and short duration make it ideal for procedures such as endotracheal intubation, electroconvulsive therapy (ECT), and brief surgical interventions. Unlike some other anesthetic agents, etomidate minimally affects cardiovascular function, making it suitable for patients with compromised hemodynamics.

In addition to its use in anesthesia, etomidate is employed for sedation in critically ill patients requiring mechanical ventilation or invasive procedures in intensive care settings. Its fast onset and short duration of action allow for precise titration of sedation levels while minimizing the risk of prolonged respiratory depression.

Etomidate has also been investigated for its potential role in the management of status epilepticus, a life-threatening neurological emergency characterized by prolonged seizures. While not commonly used as a first-line treatment, its rapid action and minimal hemodynamic effects make it a consideration in refractory cases where other treatments have failed.

Beyond its clinical applications, etomidate continues to be studied for its pharmacological properties and potential therapeutic uses. Research efforts focus on optimizing its pharmacokinetic profile to enhance its safety and efficacy in various clinical scenarios. Additionally, investigations into its molecular mechanism of action provide insights into the physiology of anesthesia induction and sedation.

Etomidate finds application in veterinary medicine for anesthesia induction in animals undergoing surgical procedures or diagnostic interventions. Its rapid onset and short duration of action make it suitable for use in a variety of veterinary settings, ranging from small animal clinics to large animal surgeries.

References

2024. The Efficacy and Safety of Propofol Versus Etomidate for Endoscopic Retrograde Cholangiopancreatography: A Systematic Review and Meta-Analysis. American Journal of Therapeutics, 31(5).
DOI: 10.1097/mjt.0000000000001705

1998. Stereoselective Effects of Etomidate Optical Isomers on Gamma-aminobutyric Acid Type A Receptors and Animals. Anesthesiology, 88(3).
DOI: 10.1097/00000542-199803000-00022

1977. The Experimental Pharmacology of Etomidate, a New Potent, Short-Acting Intravenous Hypnotic. Anaesthesiology and Resuscitation / Anaesthesiologie und Wiederbelebung / Anesthésiologie et Réanimation, Not applicable.
DOI: 10.1007/978-3-642-66787-9_1
Market Analysis Reports
List of Reports Available for Etomidate
Related Products
Etizolam  Etocrilene  Etodesnitazene  Etodolac  Etodolac methyl ester  Etodolac methyl ester  Etofamide  Etofenamate  Etofibrate  S-(-)-Etomidate  Etomidate Impurity 1  Etomoxir  Etonogestrel  Etoperidone hydrochloride  Etoposide  alpha-Etoposide  Etoposide phosphate  Etoposide 3',4'-quinone  Etoricoxib  Etoricoxib-D4